Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.
Alpizar-Rodriguez D, Brulhart L, Mueller RB, Möller B, Dudler J, Ciurea A, Walker UA, Von Mühlenen I, Kyburz D, Zufferey P, Mahler M, Bas S, Gascon D, Lamacchia C, Roux-Lombard P, Lauper K, Nissen MJ, Courvoisier DS, Gabay C, Finckh A. Alpizar-Rodriguez D, et al. Among authors: walker ua. Clin Rheumatol. 2017 Mar;36(3):677-682. doi: 10.1007/s10067-017-3547-3. Epub 2017 Jan 21. Clin Rheumatol. 2017. PMID: 28110385 Free article.
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis.
Alpizar-Rodriguez D, Mueller RB, Möller B, Dudler J, Ciurea A, Zufferey P, Kyburz D, Walker UA, von Mühlenen I, Roux-Lombard P, Mahler M, Lamacchia C, Courvoisier DS, Gabay C, Finckh A. Alpizar-Rodriguez D, et al. Among authors: walker ua. Rheumatology (Oxford). 2017 Sep 1;56(9):1579-1585. doi: 10.1093/rheumatology/kex239. Rheumatology (Oxford). 2017. PMID: 28859327
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion.
Walker UA, Courvoisier DS, Dudler J, Aeberli D, von Kempis J, Scherer A, Finckh A; Swiss Clinical Quality Management Programme in Rheumatic Diseases. Walker UA, et al. Rheumatology (Oxford). 2011 Jan;50(1):243-4. doi: 10.1093/rheumatology/keq258. Epub 2010 Aug 17. Rheumatology (Oxford). 2011. PMID: 20716674 Free article. No abstract available.
Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR database.
Iudici M, Jarlborg M, Lauper K, Müller-Ladner U, Smith V, Allanore Y, Balbir-Gurman A, Doria A, Airò P, Walker UA, Riccieri V, Vonk MC, Gabrielli A, Hoffmann-Vold AM, Szücs G, Martin T, Distler O, Courvoisier DS; EUSTAR collaborators. Iudici M, et al. Among authors: walker ua. Rheumatology (Oxford). 2022 Feb 2;61(2):743-755. doi: 10.1093/rheumatology/keab437. Rheumatology (Oxford). 2022. PMID: 33989387 Free article.
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists.
Finckh A, Möller B, Dudler J, Walker UA, Kyburz D, Gabay C; physicians of the Swiss Clinical Quality Management for Rheumatoid Arthritis; physicians of SCQM-RA. Finckh A, et al. Among authors: walker ua. Ann Rheum Dis. 2012 Oct;71(10):1680-5. doi: 10.1136/annrheumdis-2011-201016. Epub 2012 Mar 14. Ann Rheum Dis. 2012. PMID: 22419773 Free PMC article.
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
Finckh A, Ciurea A, Brulhart L, Möller B, Walker UA, Courvoisier D, Kyburz D, Dudler J, Gabay C; Arthritis. Finckh A, et al. Among authors: walker ua. Ann Rheum Dis. 2010 Feb;69(2):387-93. doi: 10.1136/ard.2008.105064. Epub 2009 May 4. Ann Rheum Dis. 2010. PMID: 19416802 Free PMC article.
257 results